Fisher Wallace Laboratories

Medical Devices for Mood and Sleep

Print
Claim My Business View on StartEngine
Security Type
Non-Voting Equity
Categories
General, Technology
Min Investment
$194
Location
Brooklyn, NY
Offering Date
October 07, 2019
Expected Close Date
September 01, 2022
Amount Raised
$123,917
Target Raise
$10K-$1M
No. Investors
125
Security Price
$8.81
Deal Notes

Security Name: Class B Non-Voting Stock

$2.50 per share

Valuation
$81,200,000
Number of Employees
12
Cash
$1,929,380
Revenue
$4,230,290
Short Term Debt
$471,468
Cost of Goods
$623,703
Long Term Debt
$576,525
Net Income
$-3,262,291

Company Description

Fisher Wallace manufactures and markets wearable medical devices for the treatment of depression, anxiety and insomnia.

Use of Proceeds

StartEngine Platform Fees: 3.5%, 

Marketing: 50.5%, 

Research & Development: 46.0

Perks

$1500+ | 42% discount on the purchase of a Fisher Wallace device
$5,000+ | Above + 2% bonus shares
$10,000+ | Above + 3% bonus shares
$20,000+ | Above + 5% bonus shares

Key Deal Facts

An FDA-Cleared, clinically validated solution for depression, anxiety and insomnia with over 50,000 patients and 10,000 prescribers in the United States
$4.7 Million net revenue in 2018 with total lifetime revenue of $23.3 Million
Named an INC 5000 fastest growing company with OTC approval in Europe, Canada, Mexico and Brazil, and recently obtained Medicaid approval in Maine (MaineCare)

Security Description

Non-voting stock is stock that provides the shareholder very little or no vote on corporate matters.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments